# RBB Bancorp: financial statements, quarterly

RBB · Nasdaq · CIK 1499422 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rbb.md) · [Financials](/companies/rbb/financials.md) · [Filings](/companies/rbb/filings.md) · [Insiders](/companies/rbb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rbb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.5](/filings/0001437749-24-034187.md) | [1.2](/filings/0001437749-24-015725.md) | [1.3](/filings/0001437749-25-016170.md) | [1.6](/filings/0001437749-25-025734.md) | [1.3](/filings/0001437749-25-033871.md) | [1.1](/filings/0001437749-25-016170.md) | [1.1](/filings/0001437749-26-015865.md) | [1.4](/filings/0001437749-26-026563.md) | [1.3](/filings/0001437749-25-033871.md) | [1.3](/filings/0001437749-26-015865.md) | [2.1](/filings/0001437749-26-026563.md) | [1.1](/filings/0001437749-26-026563.md) |
| Interest expense | $m | [28.0](/filings/0001437749-23-031921.md) | [29.2](/filings/0001437749-24-015725.md) | [29.9](/filings/0001437749-24-025500.md) | [28.9](/filings/0001437749-24-025500.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.6](/filings/0001437749-24-034187.md) | [5.0](/filings/0001437749-24-015725.md) | [3.2](/filings/0001437749-25-016170.md) | [2.5](/filings/0001437749-25-025734.md) | [2.6](/filings/0001437749-25-033871.md) | [0.7](/filings/0001437749-25-016170.md) | [0.9](/filings/0001437749-26-015865.md) | [3.6](/filings/0001437749-26-026563.md) | [3.1](/filings/0001437749-25-033871.md) | [2.6](/filings/0001437749-26-015865.md) | [4.4](/filings/0001437749-26-026563.md) | [3.9](/filings/0001437749-26-026563.md) |
| Net income | $m | [8.5](/filings/0001437749-24-034187.md) | [12.1](/filings/0001437749-24-015725.md) | [8.0](/filings/0001437749-25-016170.md) | [7.2](/filings/0001437749-25-025734.md) | [7.0](/filings/0001437749-25-033871.md) | [4.4](/filings/0001437749-25-016170.md) | [2.3](/filings/0001437749-26-015865.md) | [9.3](/filings/0001437749-26-026563.md) | [10.1](/filings/0001437749-25-033871.md) | [10.2](/filings/0001437749-26-015865.md) | [11.3](/filings/0001437749-26-026563.md) | [10.1](/filings/0001437749-26-026563.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001437749-24-034187.md) | [0.64](/filings/0001437749-24-015725.md) | [0.43](/filings/0001437749-25-016170.md) | [0.39](/filings/0001437749-25-025734.md) | [0.39](/filings/0001437749-25-033871.md) | [0.25](/filings/0001437749-25-016170.md) | [0.13](/filings/0001437749-26-015865.md) | [0.52](/filings/0001437749-26-026563.md) | [0.59](/filings/0001437749-25-033871.md) | [0.59](/filings/0001437749-26-015865.md) | [0.66](/filings/0001437749-26-026563.md) | [0.59](/filings/0001437749-26-026563.md) |
| Basic EPS | $ per share | [0.45](/filings/0001437749-24-034187.md) | [0.64](/filings/0001437749-24-015725.md) | [0.43](/filings/0001437749-25-016170.md) | [0.39](/filings/0001437749-25-025734.md) | [0.39](/filings/0001437749-25-033871.md) | [0.25](/filings/0001437749-25-016170.md) | [0.13](/filings/0001437749-26-015865.md) | [0.53](/filings/0001437749-26-026563.md) | [0.59](/filings/0001437749-25-033871.md) | [0.60](/filings/0001437749-26-015865.md) | [0.66](/filings/0001437749-26-026563.md) | [0.60](/filings/0001437749-26-026563.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [431](/filings/0001437749-25-008002.md) | not reported | [253](/filings/0001437749-24-025500.md) | [349](/filings/0001437749-24-034187.md) | [258](/filings/0001437749-26-007387.md) | [239](/filings/0001437749-25-016170.md) | [192](/filings/0001437749-25-025734.md) | [235](/filings/0001437749-25-033871.md) | [212](/filings/0001437749-26-026563.md) | [197](/filings/0001437749-26-015865.md) | [283](/filings/0001437749-26-026563.md) |
| Total assets | $m | [4,069](/filings/0001437749-23-031921.md) | [4,026](/filings/0001437749-25-008002.md) | [3,878](/filings/0001437749-25-016170.md) | [3,868](/filings/0001437749-25-025734.md) | [3,990](/filings/0001437749-25-033871.md) | [3,992](/filings/0001437749-26-007387.md) | [4,009](/filings/0001437749-26-015865.md) | [4,090](/filings/0001437749-25-033871.md) | [4,208](/filings/0001437749-25-033871.md) | [4,208](/filings/0001437749-26-026563.md) | [4,194](/filings/0001437749-26-015865.md) | [4,275](/filings/0001437749-26-026563.md) |
| Total liabilities | $m | [3,567](/filings/0001437749-23-031921.md) | [3,515](/filings/0001437749-25-008002.md) | [3,364](/filings/0001437749-24-015725.md) | [3,357](/filings/0001437749-24-025500.md) | [3,481](/filings/0001437749-24-034187.md) | [3,485](/filings/0001437749-26-007387.md) | [3,499](/filings/0001437749-25-016170.md) | [3,572](/filings/0001437749-25-025734.md) | [3,694](/filings/0001437749-25-033871.md) | [3,685](/filings/0001437749-26-026563.md) | [3,663](/filings/0001437749-26-015865.md) | [3,740](/filings/0001437749-26-026563.md) |
| Long-term debt | $m | [174](/filings/0001437749-23-031921.md) | [119](/filings/0001437749-25-008002.md) | [119](/filings/0001437749-24-015725.md) | [119](/filings/0001437749-24-025500.md) | [119](/filings/0001437749-24-034187.md) | [120](/filings/0001437749-26-007387.md) | [120](/filings/0001437749-25-016170.md) | [120](/filings/0001437749-25-025734.md) | [120](/filings/0001437749-25-033871.md) | [120](/filings/0001437749-26-026563.md) | [120](/filings/0001437749-26-015865.md) | [120](/filings/0001437749-26-026563.md) |
| Shareholders' equity | $m | [503](/filings/0001437749-24-034187.md) | [511](/filings/0001437749-26-007387.md) | [514](/filings/0001437749-25-025734.md) | [511](/filings/0001437749-25-033871.md) | [510](/filings/0001437749-25-033871.md) | [508](/filings/0001437749-26-026563.md) | [510](/filings/0001437749-26-026563.md) | [518](/filings/0001437749-26-026563.md) | [514](/filings/0001437749-25-033871.md) | [523](/filings/0001437749-26-007387.md) | [531](/filings/0001437749-26-026563.md) | [535](/filings/0001437749-26-026563.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.3 d](/filings/0001437749-24-034187.md) | [(8.8) d](/filings/0001437749-26-007387.md) | [4.8](/filings/0001437749-25-016170.md) | [11.7 d](/filings/0001437749-25-025734.md) | [24.5 d](/filings/0001437749-25-033871.md) | [17.5 d](/filings/0001437749-26-007387.md) | [7.8](/filings/0001437749-26-015865.md) | [21.7 d](/filings/0001437749-26-026563.md) | [2.1 d](/filings/0001437749-25-033871.md) | [11.8 d](/filings/0001437749-26-007387.md) | [19.4](/filings/0001437749-26-015865.md) | [22.3 d](/filings/0001437749-26-026563.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-034187.md) | [0.0 d](/filings/0001437749-26-007387.md) | [0.1](/filings/0001437749-25-016170.md) | [0.1 d](/filings/0001437749-25-025734.md) | [0.3 d](/filings/0001437749-25-033871.md) | [0.2 d](/filings/0001437749-26-007387.md) | [0.2](/filings/0001437749-25-016170.md) | [0.1 d](/filings/0001437749-25-025734.md) | [0.4 d](/filings/0001437749-25-033871.md) | [0.2 d](/filings/0001437749-26-007387.md) | not reported | not reported |
| Dividends paid | $m | [3.0 d](/filings/0001437749-24-034187.md) | [3.0 d](/filings/0001437749-26-007387.md) | [3.0](/filings/0001437749-25-016170.md) | [3.0 d](/filings/0001437749-25-025734.md) | [2.9 d](/filings/0001437749-25-033871.md) | [2.9 d](/filings/0001437749-26-007387.md) | [2.9](/filings/0001437749-26-015865.md) | [2.9 d](/filings/0001437749-26-026563.md) | [2.8 d](/filings/0001437749-25-033871.md) | [2.8 d](/filings/0001437749-26-007387.md) | [2.8](/filings/0001437749-26-015865.md) | [2.8 d](/filings/0001437749-26-026563.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-034187.md) | [6.8 d](/filings/0001437749-26-007387.md) | [1.5](/filings/0001437749-25-016170.md) | [8.1 d](/filings/0001437749-25-025734.md) | [11.0 d](/filings/0001437749-25-033871.md) | [0.0 d](/filings/0001437749-26-007387.md) | [0.0](/filings/0001437749-25-016170.md) | [1.5 d](/filings/0001437749-26-026563.md) | [12.5 d](/filings/0001437749-25-033871.md) | [(0.0) d](/filings/0001437749-26-007387.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [19.0](/filings/0001437749-24-034187.md) | [18.9](/filings/0001437749-24-015725.md) | [18.7](/filings/0001437749-25-016170.md) | [18.4](/filings/0001437749-25-025734.md) | [17.9](/filings/0001437749-25-033871.md) | [17.8](/filings/0001437749-25-016170.md) | [17.8](/filings/0001437749-26-015865.md) | [17.8](/filings/0001437749-26-026563.md) | [17.3](/filings/0001437749-25-033871.md) | [17.1](/filings/0001437749-26-015865.md) | [17.2](/filings/0001437749-26-026563.md) | [17.1](/filings/0001437749-26-026563.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,915,964 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026563.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.